Journal of the American Society of Nephrology, Vol 3, 1541-1554, Copyright © 1993 by American Society of Nephrology

REVIEWS

Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review

R Vanholder and S Ringoir

Infectious diseases remain among the most morbid events and are an important cause of death in ESRD. These events are related to an acquired immunodeficiency that progresses during the development of uremic retention, as part of the broader spectrum, displayed by the "uremic syndrome". A central role in the hose defense against bacterial infection is played by the phagocytic polymorphonuclear white blood cells, which are characterized by the capacity to ingest bacteria (phagocytosis), which is followed by the destruction of those bacteria (killing capacity). This article reviews the mechanisms of development and the potential causes that have been held responsible for this aspect of the defective immune function. The observed changes are attributed to alterations in receptor expression, although more convincing evidence points in the direction of metabolic functional disturbances, especially in the NAD(P)H-oxidase-dependent production of oxygen free radicals. The most important causative factors are: uremic toxicity, iron overload, renal anemia, dialyzer bioincompatibility, and the type of renal replacement therapy. It is concluded that the phagocytic defect in ESRD is multifactorial and that each factor should be managed by specific therapeutic approaches.

This article has been cited by other articles:

				M. T. James, K. B. Laupland, M. Tonelli, B. J. Manns, B. F. Culleton, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network Risk of Bloodstream Infection in Patients With Chronic Kidney Disease Not Treated With Dialysis Arch Intern Med, November 24, 2008; 168(21): 2333 - 2339. [Abstract] [Full Text] [PDF]

				L. S. Dalrymple and A. S. Go Epidemiology of Acute Infections among Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1487 - 1493. [Abstract] [Full Text] [PDF]

				H. Guo, J. Liu, A. J. Collins, and R. N. Foley Pneumonia in incident dialysis patients--the United States Renal Data System Nephrol. Dial. Transplant., February 1, 2008; 23(2): 680 - 686. [Abstract] [Full Text] [PDF]

				E. Schepers, N. Meert, G. Glorieux, J. Goeman, J. Van der Eycken, and R. Vanholder P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production Nephrol. Dial. Transplant., February 1, 2007; 22(2): 592 - 596. [Abstract] [Full Text] [PDF]

				L. Ottonello, P. Gnerre, M. Bertolotto, M. Mancini, P. Dapino, R. Russo, G. Garibotto, T. Barreca, and F. Dallegri Leptin as a Uremic Toxin Interferes with Neutrophil Chemotaxis J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2366 - 2372. [Abstract] [Full Text] [PDF]

				M. Tamano, H. Ohi, S. Sudo, and Y. Tomino Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1467 - 1473. [Abstract] [Full Text] [PDF]

				E. A. J. Hoste, S. I. Blot, N. H. Lameire, R. C. Vanholder, D. De Bacquer, and F. A. Colardyn Effect of Nosocomial Bloodstream Infection on the Outcome of Critically Ill Patients with Acute Renal Failure Treated with Renal Replacement Therapy J. Am. Soc. Nephrol., February 1, 2004; 15(2): 454 - 462. [Abstract] [Full Text] [PDF]

				S. Ahmed, N. Gibbons, and J. Mattana Oxidized Immunoglobulin G in Patients with End-Stage Renal Disease Treated by Hemodialysis Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 11 - 17. [Abstract] [Full Text] [PDF]

				C. E. Lok, K. E. Stanley, J. E. Hux, R. Richardson, S. W. Tobe, and J. Conly Hemodialysis Infection Prevention with Polysporin Ointment J. Am. Soc. Nephrol., January 1, 2003; 14(1): 169 - 179. [Abstract] [Full Text] [PDF]

				W. H. Horl Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71. [Abstract] [Full Text] [PDF]

				M. J. Sarnak and B. L. Jaber Pulmonary Infectious Mortality Among Patients With End-Stage Renal Disease Chest, December 1, 2001; 120(6): 1883 - 1887. [Abstract] [Full Text] [PDF]

				K. Gastaldello, C. Husson, R. Wens, J.-L. Vanherweghem, and C. Tielemans Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1638 - 1646. [Abstract] [Full Text] [PDF]

				B. MEMOLI, L. MARZANO, V. BISESTI, M. ANDREUCCI, and B. GUIDA Hemodialysis-Related Lymphomononuclear Release of Interleukin-12 in Patients with End-Stage Renal Disease J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2171 - 2176. [Abstract] [Full Text]

				E. FIACCADORI, M. LOMBARDI, S. LEONARDI, C. F. ROTELLI, G. TORTORELLA, and A. BORGHETTI Prevalence and Clinical Outcome Associated with Preexisting Malnutrition in Acute Renal Failure: A Prospective Cohort Study J. Am. Soc. Nephrol., March 1, 1999; 10(3): 581 - 593. [Abstract] [Full Text]

				T. Joko, H. Tanaka, H. Hirakata, H. Henzan, K. Hizawa, E. Hirakata, H. Higashi, H. Yonemasu, and M. Fujishima Phlegmonous gastritis in a haemodialysis patient with secondary amyloidosis Nephrol. Dial. Transplant., January 1, 1999; 14(1): 196 - 198. [PDF]

				M. CENDOROGLO, B. L. JABER, V. S. BALAKRISHNAN, M. PERIANAYAGAM, A. J. KING, and B. J. G. PEREIRA Neutrophil Apoptosis and Dysfunction in Uremia J. Am. Soc. Nephrol., January 1, 1999; 10(1): 93 - 100. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673